Descriptor English: | Bromodeoxyuridine | ||||||
Descriptor Spanish: |
Bromodesoxiuridina
| ||||||
Descriptor Portuguese: | Bromodesoxiuridina | ||||||
Descriptor French: | Broxuridine | ||||||
Entry term(s): |
5 Bromo 2' deoxyuridine 5 Bromodeoxyuridine 5-Bromo-2'-deoxyuridine 5-Bromodeoxyuridine BUdR BrdU Bromouracil Deoxyriboside Broxuridine Deoxyriboside, Bromouracil NSC-38297 |
||||||
Tree number(s): |
D03.383.742.680.852.300.150 D13.570.230.430.196 D13.570.685.852.300.150 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D001973 | ||||||
Scope note: | A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Antimetabolites Antimetabolites, Antineoplastic Antiviral Agents Radiation-Sensitizing Agents |
||||||
Registry Number: | G34N38R2N1 | ||||||
CAS Type 1 Name: | Uridine, 5-bromo-2'-deoxy- | ||||||
Public MeSH Note: | 66 |
||||||
History Note: | 66(65) |
||||||
DeCS ID: | 2002 | ||||||
Unique ID: | D001973 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1966/01/01 | ||||||
Date of Entry: | 1999/01/01 | ||||||
Revision Date: | 2016/05/27 |
-
-
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds
|
Bromodeoxyuridine
- Preferred
NSC-38297
- Narrower
Concept UI |
M0002951 |
Scope note | A nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite. It causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent. It has been given orphan drug status for use in the treatment of primary brain tumors. |
Preferred term | Bromodeoxyuridine |
Entry term(s) |
5 Bromo 2' deoxyuridine 5 Bromodeoxyuridine 5-Bromo-2'-deoxyuridine 5-Bromodeoxyuridine BUdR BrdU Bromouracil Deoxyriboside Broxuridine Deoxyriboside, Bromouracil |
Concept UI |
M0373518 |
Preferred term | NSC-38297 |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey